Revvity Shares Surge Following Q3 Earnings Beat and Increased 2026 Guidance
Revvity (RVTY) shares rose approximately 11% in Tuesday morning trading after the life sciences tools and diagnostics company reported third-quarter financial results that exceeded analyst expectations for both revenue and profit. The positive market reaction was driven by the company's decision to raise its full-year guidance for 2026, specifically increasing its non-GAAP earnings per share (EPS) forecasts. This upward revision reflects stronger-than-anticipated operational performance and growth momentum within its core business segments.
Tickers: $RVTY
Topics: earnings beat life sciences profit forecast revenue forecast